arrow
D

Dustin J. Little

AstraZeneca
H指数:19
被引数:1,398

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Changing paradigms of studies in kidney diseases

肾脏疾病研究范式的转变

2025-09-290
OAAI
A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) Collaboration

支持慢性肾病替代终点沟通与接受的战略路线图:慢性肾病替代终点接受度(RESET CKD)合作

2025-09-230
OAAI
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF

心力衰竭中的铁缺乏和达格列净的影响: DAPA-HF的发现

2022-09-2778
OAAI
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD Pooled Results of Three Randomized Clinical Trials

罗沙司他治疗非透析依赖性CKD患者贫血的疗效和心血管安全性3项随机临床试验的汇总结果

2021-08-0162
OA
RETRACTED: Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis (Retracted article. See vol. 7, pg. 665, 2022)

撤回: 罗沙司他对透析后肾衰竭患者贫血的汇总分析 (撤回文章。见第7卷,665页,2022)

2021-03-0133
OAAI